Northern Trust’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
Other funds holding CGON
Northern Trust's CGON Position: Q3 2026 in Review
Northern Trust reduced its CG Oncology (CGON) stake by 0.05% in Q3 2026, selling an estimated $24.7K and leaving 677,576 shares worth $48M. The position accounts for 0.01% of the portfolio, ranked #1168.
Northern Trust first reported a position in CGON in Q1 2024 and has held it in 11 quarters since. The position peaked at $48.2M in Q2 2026. 233 funds tracked by Wall St. Rank hold CGON as of Q3 2026.
- Northern Trust held 677,576 shares of CG Oncology worth $48M as of Q3 2026.
- Northern Trust sold 336 CG Oncology shares in Q3 2026, an estimated $24.7K.
- CG Oncology made up 0.01% of Northern Trust's portfolio in Q3 2026, its #1168 holding.
- Northern Trust first reported a position in CG Oncology in Q1 2024 and has held it in 11 quarters since.
- Northern Trust's CG Oncology position peaked at $48.2M in Q2 2026.
- 233 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.
Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.